The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 27, 2015

Filed:

Apr. 10, 2012
Applicants:

Vincent Lotteau, Lyons, FR;

Benoit DE Chassey, Lyons, FR;

Patrice Andre, Lyons, FR;

Laurene Meyniel-schicklin, Lyons, FR;

Anne Aublin-gex, Lyons, FR;

Inventors:

Vincent Lotteau, Lyons, FR;

Benoit De Chassey, Lyons, FR;

Patrice Andre, Lyons, FR;

Laurene Meyniel-Schicklin, Lyons, FR;

Anne Aublin-Gex, Lyons, FR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/145 (2006.01); A61K 31/198 (2006.01); A61K 31/122 (2006.01); A61K 31/337 (2006.01); A61K 31/352 (2006.01); A61K 31/404 (2006.01); A61K 31/426 (2006.01); A61K 31/4465 (2006.01); A61K 31/4745 (2006.01); A61K 31/475 (2006.01); A61K 31/55 (2006.01); A61K 31/555 (2006.01); A61K 31/58 (2006.01); A61K 31/7068 (2006.01); A61K 31/7076 (2006.01); A61K 38/06 (2006.01); A61K 45/06 (2006.01); A61K 38/00 (2006.01); A61K 38/21 (2006.01);
U.S. Cl.
CPC ...
A61K 31/198 (2013.01); A61K 31/122 (2013.01); A61K 31/337 (2013.01); A61K 31/352 (2013.01); A61K 31/404 (2013.01); A61K 31/426 (2013.01); A61K 31/4465 (2013.01); A61K 31/475 (2013.01); A61K 31/4745 (2013.01); A61K 31/55 (2013.01); A61K 31/555 (2013.01); A61K 31/58 (2013.01); A61K 31/7068 (2013.01); A61K 31/7076 (2013.01); A61K 38/005 (2013.01); A61K 38/063 (2013.01); A61K 38/21 (2013.01); A61K 45/06 (2013.01);
Abstract

The present invention relates to methods and pharmaceutical compositions for inhibiting influenza virus replication. More particularly, the present invention relates to a compound selected from the group consisting of Gemcitabine, Obatoclax Mesylate, Docetaxel, HA-14, Alsterpaullone, GSK3B inhibitor VIII, GSK3B inhibitor XV, Indirubin 3'-monoxime, L glutathione reduced, Fluocinolone acetonide, Tirofiban, Topotecan hydrochloride, Clofarabine, Vinblastine, Menadione Crystalline and derivatives or analogues thereof for use in the treatment of an influenza infection in a subject in need thereof.


Find Patent Forward Citations

Loading…